Anzu Special Acquisition Corp I Cl A (ANZU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANZU | TMO | ISRG | ALC | IQV |
| Company | Anzu Special Acquisition Corp I Cl A | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Alcon Inc | Iqvia Holdings Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 5.42 | 616.11 | 489.16 | 97.39 | 251.01 |
| High | 7.53 | 618.00 | 493.44 | 97.98 | 251.96 |
| Low | 5.24 | 605.00 | 485.28 | 96.45 | 246.85 |
| Last | 7.02 | 615.07 | 492.63 | 97.68 | 251.55 |
| Change | +1.38 | +3.39 | +5.46 | +0.45 | +0.76 |
| % Change | +24.38% | +0.55% | +1.12% | +0.46% | +0.30% |
| Volume | 157,200 | 1,058,900 | 1,097,700 | 758,400 | 1,194,400 |
| 20-Day Average Volume | 77,605 | 1,080,125 | 1,187,545 | 790,430 | 802,150 |
| Previous Close | 5.64 | 611.68 | 487.17 | 97.23 | 250.79 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.78 | 604.74 | 474.02 | 94.26 | 241.90 |
| 20-Day Raw Stochastic | 27.73% | 90.60% | 97.92% | 96.49% | 94.39% |
| 20-Day Relative Strength | 26.37% | 60.26% | 65.95% | 63.66% | 60.65% |
| Weighted Alpha | -23.10 | +15.59 | +66.03 | +25.99 | +17.30 |
| Today's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -32.74% since 09/22/23 | +1.48% since 08/23/24 | +1.25% since 08/23/24 | +1.65% since 08/23/24 | +1.05% since 08/23/24 |
| Low | 5.21 on 09/28/23 | 602.00 on 08/27/24 | 476.88 on 08/26/24 | 95.14 on 08/26/24 | 245.56 on 08/27/24 |
| High | 11.72 on 09/26/23 | 618.00 on 08/30/24 | 493.44 on 08/30/24 | 97.98 on 08/30/24 | 252.88 on 08/29/24 |
| 1-Month | |||||
| %Chg | -32.35% since 08/29/23 | unch since 07/30/24 | +13.85% since 07/30/24 | +4.56% since 07/30/24 | +2.44% since 07/30/24 |
| Low | 5.21 on 09/28/23 | 585.68 on 08/07/24 | 429.60 on 08/05/24 | 89.44 on 08/05/24 | 229.17 on 08/08/24 |
| High | 11.72 on 09/26/23 | 622.30 on 08/01/24 | 493.97 on 08/23/24 | 97.98 on 08/30/24 | 252.88 on 08/29/24 |
| 3-Month | |||||
| %Chg | -31.49% since 06/29/23 | +9.30% since 05/30/24 | +22.12% since 05/30/24 | +10.56% since 05/30/24 | +13.08% since 05/30/24 |
| Low | 5.21 on 09/28/23 | 528.37 on 07/09/24 | 396.48 on 05/31/24 | 87.79 on 07/10/24 | 205.06 on 07/05/24 |
| High | 11.72 on 09/26/23 | 622.30 on 08/01/24 | 493.97 on 08/23/24 | 97.98 on 08/30/24 | 252.88 on 08/29/24 |
| 6-Month | |||||
| %Chg | -29.78% since 03/29/23 | +7.87% since 02/29/24 | +27.76% since 02/29/24 | +15.53% since 02/29/24 | +1.78% since 02/29/24 |
| Low | 5.21 on 09/28/23 | 528.37 on 07/09/24 | 364.17 on 04/19/24 | 77.54 on 04/30/24 | 205.06 on 07/05/24 |
| High | 11.72 on 09/26/23 | 622.30 on 08/01/24 | 493.97 on 08/23/24 | 97.98 on 08/30/24 | 261.73 on 03/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,790 | 234,782,064 | 174,735,856 | 48,166,008 | 45,832,408 |
| Shares Outstanding, K | 14,938 | 381,716 | 354,700 | 493,100 | 182,200 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 9,455,000,000 | 14,984,000,000 |
| Annual Net Income | 19,230,000 | 5,995,000,000 | 1,798,000,000 | 974,000,000 | 1,358,000,000 |
| Last Quarter Sales | 0 | 10,541,000,000 | 2,009,900,000 | 2,496,000,000 | 3,814,000,000 |
| Last Quarter Net Income | -1,140,000 | 1,547,000,000 | 526,900,000 | 223,000,000 | 363,000,000 |
| 60-Month Beta | 0.03 | 0.77 | 1.39 | 0.97 | 1.49 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.37 on 07/24/24 | 1.78 on 07/18/24 | 0.74 on 08/20/24 | 2.64 on 07/22/24 |
| Latest Earnings Date | N/A | 10/23/24 | 10/17/24 | 08/20/24 | 07/22/24 |
| Most Recent Dividend | N/A | 0.390 on 06/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 09/13/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.01 | 98.02 | 33.76 | 25.91 |